Atlas Trials

A Prospective Cohort Study:Forecast Fracture Risk With a Serum Marker of Type 2 Diabetes in Guangzhou Community

Clinical trial NCT03456271 · TERMINATED

Trial details

NCT number
NCT03456271
Sponsor
Zhujiang Hospital
Status
TERMINATED
Study type
OBSERVATIONAL
Type 2 Diabetes Mellitus and Fragility Fractures
Start date
2017-07-01
Primary completion
2021-11-30
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.